Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and / Najlacnejšie knihy
Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and

Kod: 05284264

Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and

Autor Malik Osmane

Master's Thesis from the year 2013 in the subject Medicine - Pharmacology, grade: 1 st CLASS HONS, Dublin Institute of Technology (Chemistry), course: Pharmaceutical Quality Assurance / Regulatory Affairs, language: English, abstr ... więcej

124.33

Zwykle: 126.87 €

Oszczędzasz 2.55 €


Dostępna u dostawcy
Wysyłamy za 15 - 20 dni
Dodaj do schowka

Zobacz książki o podobnej tematyce

Podaruj tę książkę jeszcze dziś
  1. Zamów książkę i wybierz "Wyślij jako prezent".
  2. Natychmiast wyślemy Ci bon podarunkowy, który możesz przekazać adresatowi prezentu.
  3. Książka zostanie wysłana do adresata, a Ty o nic nie musisz się martwić.

Dowiedz się więcej

Więcej informacji o Rift-lines within European regulatory framework for Biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and

Za ten zakup dostaniesz 312 punkty

Opis

Master's Thesis from the year 2013 in the subject Medicine - Pharmacology, grade: 1 st CLASS HONS, Dublin Institute of Technology (Chemistry), course: Pharmaceutical Quality Assurance / Regulatory Affairs, language: English, abstract: During the course of this thesis evidence was presented and discussed related to the research questions. The fundamental question related to the heterogeneity and variation through the life cycle of the biosimilar and the reference biologic remains neglected, based on the results collected during this thesis, by the stakeholders, mainly because those issues where not addressed in any official regulatory guidance document. §As clear guidance from the EMA is lacking, with the only available guidance being that once a marketing authorization is issued it is accepted that the quality profiles of the reference biologic and the biosimilar will have different quality profiles. §Abstract:§Within the biosimilar development context, there are unaddressed questions by the European Medicines Agency (EMA) with regard to the impacts of shifts of the quality profile (purity- and impurity levels) of the reference biologic for the biosimilar development program. This dynamic is an open issues has potentially implications on the comparability exercise of the before mentioned.§Opinions from experts involved in the guidance drafting process of EMA and other were evaluated with regard to the issue.[...]

Szczegóły książki

Kategoria Książki po angielsku Medicine Nursing & ancillary services Pharmacy / dispensing

124.33

Ulubione w innej kategorii



Osobní odběr Bratislava a 2642 dalších

Copyright ©2008-24 najlacnejsie-knihy.sk Wszelkie prawa zastrzeżonePrywatnieCookies


Konto: Logowanie
Všetky knihy sveta na jednom mieste. Navyše za skvelé ceny.

Nákupní košík ( prázdný )

Nakupte za 59,99 € a
máte doručení zdarma.

Twoja lokalizacja: